Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients clinical trial (NCT00754364). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the effectiveness of carboplatin plus pemetrexed compare to gemcitabine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients clinical trial (NCT00754364). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of each treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients clinical trial (NCT00754364). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients clinical trial (NCT00754364). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment cycles?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients clinical trial (NCT00754364). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients clinical trial (NCT00754364). Contact the study team or your healthcare provider for specific answers.

What this study is about